These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7426253)

  • 1. Screening of certain anaesthetic agents for their ability to elicit acute porphyric phases in susceptible patients.
    Blekkenhorst GH; Harrison GG; Cook ES; Eales L
    Br J Anaesth; 1980 Aug; 52(8):759-62. PubMed ID: 7426253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of beta-adrenergic blocking agents on experimental porphyria induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) in vivo and in vitro.
    Schoenfeld N; Epstein O; Atsmon A
    Biochim Biophys Acta; 1976 Aug; 444(1):286-93. PubMed ID: 8132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyrinogenicity of etomidate and ketamine as continuous infusions. Screening in the DDC-primed rat model.
    Harrison GG; Moore MR; Meissner PN
    Br J Anaesth; 1985 Apr; 57(4):420-3. PubMed ID: 3986071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of certain anaesthetic agents on the activity of rat hepatic delta-aminolaevulinate synthase.
    Parikh RK; Moore MR
    Br J Anaesth; 1978 Nov; 50(11):1099-103. PubMed ID: 718778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies in laboratory animals to assess the safety of anti-inflammatory agents in acute porphyria.
    McColl KE; Thompson GG; Moore MR
    Ann Rheum Dis; 1987 Jul; 46(7):540-2. PubMed ID: 3662642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clonidine in a primed rat model of acute hepatic porphyria.
    Goerz G; Bolsen K; Böhrer H; Fritsch C; Kalka K; Rominger KL
    Arzneimittelforschung; 1997 Jun; 47(6):731-3. PubMed ID: 9239451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the rat in the experimental investigation of the porphyrias.
    Eales L; Blekkenhorst GH
    J S Afr Vet Assoc; 1978 Sep; 49(3):249-51. PubMed ID: 745206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lead on hepatic delta-aminolaevulinic acid synthetase activity in the rat: a model for drug sensitivity in intermittent acute porphyria.
    Maxwell JD; Meyer UA
    Eur J Clin Invest; 1976 Sep; 6(5):373-9. PubMed ID: 976299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. delta-Aminolevulinate synthetases in the liver cytosol fraction and mitochondria of mice treated with allylisopropylacetamide and 3,5-dicarbethoxyl-1,4-dihydrocollidine.
    Igarashi J; Hayashi N; Kikuchi G
    J Biochem; 1976 Nov; 80(5):1091-9. PubMed ID: 1002680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Studies in rats and mice.
    De Matteis F; Abbritti G; Gibbs AH
    Biochem J; 1973 Jul; 134(3):717-27. PubMed ID: 4749272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A difference between two strains of rats in their liver non-haem iron content and in their response to the porphyrogenic effect of hexachlorobenzene.
    Smith AG; Cabral JR; De Matteis F
    Chem Biol Interact; 1979 Oct; 27(2-3):353-63. PubMed ID: 498361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribonucleic acid synthesis in porphyric rat liver induced by 3,5-dicarbethoxy-1,4-dihydrocollidine.
    Nawata H; Kato K
    Biochem J; 1973 Sep; 136(1):209-15. PubMed ID: 4772623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental latent and acute porphyria in the non-fasted rat; preventive effect of propranolol.
    Schoenfeld N; Mamet R; Mevasser R; Atsmon A
    Scand J Clin Lab Invest; 1991 Dec; 51(8):667-73. PubMed ID: 1806982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the effects of certain drugs on experimental porphyria in rats.
    Deshpande SG; Kandhari KC; Narang BS; Bikhchandani R; Bhutani LK
    Dermatologica; 1977; 154(5):284-90. PubMed ID: 863070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of glucose metabolism enzymes in an acute porphyria model. Role of reactive oxygen species.
    Lelli SM; San Martín de Viale LC; Mazzetti MB
    Toxicology; 2005 Dec; 216(1):49-58. PubMed ID: 16125296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of actinomycin D on the activity of delta-aminolaevulinic acid synthetase and dehydratase in the liver of mice and rats treated by griseofulvin.
    Erban J; Janousek V
    Physiol Bohemoslov; 1977; (2):173-8. PubMed ID: 140391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic alteration of tryptophan metabolism in an acute porphyria model Its relation with gluconeogenic blockage.
    Lelli SM; Mazzetti MB; San Martín de Viale LC
    Biochem Pharmacol; 2008 Feb; 75(3):704-12. PubMed ID: 17996218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. delta-aminolevulinic acid synthetase from the particulate fraction of liver of porphyric rats.
    Kaplan BH
    Biochim Biophys Acta; 1971 May; 235(2):381-8. PubMed ID: 5317642
    [No Abstract]   [Full Text] [Related]  

  • 19. PK 11195 aggravates 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced hepatic porphyria in rats.
    Fonia O; Weizman R; Coleman R; Kaganovskaya E; Gavish M
    Hepatology; 1996 Sep; 24(3):697-701. PubMed ID: 8781345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of liver 5-aminolaevulinate synthetase by drugs and its relevance to drug-induced accumulation of cytochrome P-450. Studies with phenylbutazone and 3,5-diethoxycarbonyl-1,4-dihydrocollidine.
    De Matteis F; Gibbs A
    Biochem J; 1972 Mar; 126(5):1149-60. PubMed ID: 5073727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.